Susan L. Cohn to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Susan L. Cohn has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.171
-
Advances in the treatment of neuroblastoma. Clin Adv Hematol Oncol. 2011 Nov; 9(11):865-7.
Score: 0.098
-
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group. Clin Cancer Res. 2018 01 01; 24(1):189-196.
Score: 0.037
-
The Role of Nursing Professionals in the Management of Patients With High-Risk Neuroblastoma Receiving Dinutuximab Therapy. J Pediatr Oncol Nurs. 2017 May/Jun; 34(3):160-172.
Score: 0.035